Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis

Frontiers in Pharmacology

Nicoletta Pedemonte¹  Miquéias Lopes-Pacheco²  Anthony Kicic³ 

[1] Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal;;Biosystems &Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA, Australia;Occupation and Environment, School of Public Health, Curtin University, Bentley, WA, Australia;Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia;UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genova, Italy;

关键词: cystic fibrosis transmembrane conductance regulator;    mutations;    therapeutic approach;    drug development;    lung;    inflammation;   

DOI  :  10.3389/fphar.2019.01440

来源: DOAJ

【 授权许可】

Unknown